Tumor Markers Method Conversion and Re-Baseline Period

In preparation for the upcoming chemistry instrumentation and methodology change for tumor marker testing on November 10, 2023, CompuNet began its re-baseline period on September 11, 2023. It is strongly recommended that clinicians re-establish baseline tumor marker levels on the new method for AFP, CEA, CA 125, CA 15-3, and CA 19-9 during this time, as values from different assay methods and instruments are not interchangeable. For any testing ordered during this re-baseline period, the laboratory will automatically perform and report results from the current and new platforms to help clinicians evaluate the differences between the methods. The re-baseline will be at no additional charge to the patient. 

Back to the October 2023 issue of Premier Pulse